Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci. 2006 Jul 17; 7:56.
View in:
PubMed
subject areas
Animals
Anti-Inflammatory Agents
Apoptosis
Blood-Brain Barrier
Brain
Brain Ischemia
Disease Models, Animal
Drug Administration Schedule
Encephalitis
Enzyme Activation
Enzyme Inhibitors
Extracellular Matrix
Male
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinases
Minocycline
Nerve Degeneration
Neuroprotective Agents
Rats
Rats, Wistar
Stroke
Time Factors
Treatment Outcome
authors with profiles
Adviye Ergul